Skip to main content

Lartruvo

olaratumab
Used for Soft Tissue Sarcoma

Lartruvo (olaratumab) is an injectable medication that's given together with doxorubicin (Adriamycin) for the treatment of soft tissue sarcoma (STS) in adults who can't get surgery or radiotherapy. This medication was taken off the market and is no longer available in the U.S.

Reviewed by:Last reviewed on July 31, 2022
basics-icon

What is Lartruvo (olaratumab)?

What is Lartruvo (olaratumab) used for?

  • Soft tissue sarcoma (STS)

Drug facts

Common BrandsLartruvo(brand no longer available)
Drug ClassAnticancer
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityDiscontinued
dosage-icon

Lartruvo (olaratumab) dosage

Typical dosage for Lartruvo (olaratumab)